The rise of online medicine sales has created new opportunities for access-but also unprecedented risks from substandard and falsified (SF) products. This moderated session will examine the growing challenge of unsafe online pharmacies and explore evidence-based strategies to protect consumers. Panelists will discuss the roles of healthcare providers, regulators, and industry partners in strengthening public awareness, digital verification systems, and technology-enabled traceability tools. The discussion will highlight innovative approaches, policy responses, and cross-sector collaboration needed to safeguard patients in the expanding digital health marketplace.
The rise of online medicine sales has created new opportunities for access-but also unprecedented risks from substandard and falsified (SF) products. This moderated session will examine the growing challenge of unsafe online pharmacies and explore evidence-based strategies to protect consumers. Panelists will discuss the roles of healthcare providers, regulators, and industry partners in strengthening public awareness, digital verification systems, and technology-enabled traceability tools. The discussion will highlight innovative approaches, policy responses, and cross-sector collaboration needed to safeguard patients in the expanding digital health marketplace.
BESAFE2025 besafe@jh.eduProblemas técnicos?
Si tienes problemas de reproducción, prueba a ajustar la calidad o a actualizar la página.
Preguntas para los ponentes?
Usa la pestaña de Preguntas y respuestas para enviar preguntas que podrían abordarse en sesiones de seguimiento.
